5299 篇
13868 篇
408779 篇
16079 篇
9269 篇
3869 篇
6464 篇
1238 篇
72401 篇
37108 篇
12060 篇
1619 篇
2821 篇
3387 篇
640 篇
1229 篇
1965 篇
4866 篇
3821 篇
5293 篇
全球microRNA市场报告(2012-2016年)
Global MicroRNA Market(2012-2016)
01. Executive Summary
02. Scope of the Report
02.1 Market Overview
02.2 Product Offerings
03. Market Research Methodology
03.1 Market Research Process
03.2 Research Design
03.3 Research Methodology
04. List of Abbreviations
05. Introduction
06. Market Landscape
06.1 Market Overview
07. Global MicroRNA Research Market
07.1 Overview of the Global MicroRNA Research Market
07.2 Models Employed for MicroRNA Research
07.3 Fields Covered by MicroRNA Research
08. Global MicroRNA Market
08.1 Market Size and Forecast
08.2 Five Forces Analysis
09. Market Segmentation by Application
09.1 Overview
09.2 Global MicroRNA Market Segmentation by Application 2012
09.3 Global MicroRNA Market Segmentation by Application 2012-2016
10. Global MicroRNA Tools and Reagents Market
10.1 Market Size and Forecast
10.2 Global MicroRNA Expression Profiling Market Segmentation by Technology
10.3 Global MicroRNA Tools and Reagents Market Segmentation by Geography
11. Global MicroRNA Therapeutics Market
11.1 Market Size and Forecast
12. Global MicroRNA Diagnostics Market
12.1 Market Size and Forecast
13. Geographical Segmentation
13.1 Global MicroRNA Market Segmentation by Geography 2012
13.2 Global MicroRNA Market Segmentation by Geography 2012-2016
13.3 MicroRNA Market in North America
13.3.1 Market Size and Forecast
13.4 MicroRNA Market in Europe
13.4.1 Market Size and Forecast
13.5 MicroRNA Market in ROW
13.5.1 Market Size and Forecast
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.2 Key Vendor Ranking 2012
21.3 Other Prominent Vendors
22. Key Vendor Analysis
22.1 Alnylam Pharmaceuticals Inc.
22.1.1 Business Overview
22.1.2 Business Segmentation
22.1.3 Key Information
22.1.4 SWOT Analysis
22.2 Exiqon A/S
22.2.1 Business Overview
22.2.2 Business Segmentation
22.2.3 Key Information
22.2.4 SWOT Analysis
22.3 Santaris Pharma A/S
22.3.1 Business Overview
22.3.2 Business Segmentation
22.3.3 Key Information
22.3.4 SWOT Analysis
23. Other Reports in this Series